05.05.2016 Views

Lexapro (Major Depressive Disorder) Market Statistics & Industry Facts To 2023

Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD.

Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

- Make more informed business decisions from insightful and in-depth analysis of <strong>Lexapro</strong><br />

performance<br />

- Obtain sales forecast for <strong>Lexapro</strong> from 2013-<strong>2023</strong> in the top eight countries (the US, France,<br />

Germany, Italy, Spain, the UK, Japan and Australia).<br />

Table Of Content:<br />

1 Table of Contents 5<br />

1.1 List of Tables 7<br />

1.2 List of Figures 7<br />

2 Introduction 8<br />

2.1 Catalyst 8<br />

2.2 Related Reports 8<br />

2.3 Upcoming Related Reports 10<br />

Get Sample Copy of Report here: http://www.radiantinsights.com/research/lexapro-majordepressive-disorder-forecast-and-market-analysis-to-<strong>2023</strong>#tabs-4<br />

3 Disease Overview 11<br />

3.1 Etiology and Pathophysiology 11<br />

3.1.1 Etiology 11<br />

3.1.2 Pathophysiology 11<br />

3.2 Classification 13<br />

3.3 Symptoms and Subtypes of <strong>Major</strong> <strong>Depressive</strong> <strong>Disorder</strong> 15<br />

3.4 Prognosis 16<br />

3.5 Quality of Life 16<br />

4 Disease Management 17<br />

4.1 Diagnosis and Treatment Overview 17<br />

4.1.1 Diagnosis 17<br />

4.1.2 Treatment Guidelines and Leading Prescribed Drugs 18<br />

4.1.3 Clinical Practice 21<br />

5 Competitive Assessment 26<br />

5.1 Overview 26<br />

6 <strong>Lexapro</strong> (Escitalopram) 28<br />

6.1 Overview 28<br />

6.2 Efficacy 29<br />

6.3 Safety 30<br />

6.4 SWOT Analysis 31<br />

6.5 Forecast 32<br />

7 Appendix 33

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!